COMMUNIQUÉS West-GlobeNewswire

Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation
18/04/2024
Proceeds Will Help Protect Oceans, Waves and Beaches for All People to Enjoy MONTAUK, N.Y., April 18, 2024 (GLOBE NEWSWIRE) -- Montauk Brewing Company (“Montauk Brewing” or “Montauk”), the leading and fastest-selling [...]
Canadian Men's Health Foundation names Kenton Boston as President & CEO
18/04/2024
VANCOUVER, British Columbia, April 18, 2024 (GLOBE NEWSWIRE) -- The Canadian Men’s Health Foundation ’s (CMHF) board of directors is proud to announce the appointment of Kenton Boston as President & Chief Executive [...]
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
18/04/2024
WILMETTE, Ill., April 18, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced [...]
23andMe announces CEO’s intention to pursue a potential take-private
18/04/2024
SOUTH SAN FRANCISCO, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, has been made aware that Anne Wojcicki, Chief Executive Officer, [...]
Volta Medical Announces Presentations at Heart Rhythm Society 2024 in Boston, MA, USA
18/04/2024
• Demonstration of Volta AF-Xplorer™ at Heart Rhythm Society (HRS) 2024, May 16-19 • Dr. Andrea Natale, a world recognized leader in the field of electrophysiology, to moderate Rhythm Theater MARSEILLE, France, April 18 [...]
Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
18/04/2024
Media Release Centre for Human Drug Research (CHDR) will conduct Phase I trial to evaluate IMP761, a first-in-class LAG-3 agonist antibody designed to restore balance to the immune system and address the underlying [...]
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024
18/04/2024
LANGHORNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
American Shared Hospital Services Strengthens Senior Management Structure
18/04/2024
SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced [...]
Panbela Announces Poster Presentation at American Association for Cancer Research:
18/04/2024
Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovarian cancer models MINNEAPOLIS, April 18, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (OTCQB: PBLA)(“Panbela”), [...]
New Field Data Shows High Diagnostic Yield for Lung Biopsy Diagnosis Using the Galaxy System™
18/04/2024
Noah Medical white papers based on data collected from D. Kyle Hogarth, MD and Amit Mahajan, MD demonstrate power of integrated Imaging to overcome CT-to-body divergence in navigated bronchoscopy SAN CARLOS, Calif., [...]
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
18/04/2024
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and [...]
Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
18/04/2024
Research on breast, colorectal, head and neck, and testicular cancers Novel downregulation of WNK1 and Wnt signaling KNOXVILLE, TN, April 18, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or [...]
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
18/04/2024
WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for [...]
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
18/04/2024
BOSTON, April 18, 2024 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on providing innovative medical therapies that create positive patient stories in the hospital, community and [...]
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
18/04/2024
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI ® (ublituximab-xiiy) in [...]
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
18/04/2024
-First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- - BB-301 facilitated improvements across multiple [...]
Castellum, Inc. Announces New Strategic Alliance
18/04/2024
VIENNA, Va,, April 18, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces a new [...]
Aveanna Announces First Quarter 2024 Earnings Release Date and Conference Call
18/04/2024
ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 9, [...]
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
18/04/2024
WAYNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on [...]

Pages